Metabolic Dysfunction

The FDA has granted 510(k) clearance to Nanox’s HealthFLD artificial intelligence software to aid clinicians in the detection of fatty liver associated with hepatic steatosis, according to a company press release.

In a Healio video exclusive, Edward V. Loftus Jr., MD, highlighted how rebranding nonalcoholic fatty liver disease as metabolic dysfunction-associated steatotic liver disease offers a “positive diagnosis” without the associated stigma.

In June 2023, 74% of respondents from a multinational, multisociety Delphi process agreed that the term nonalcoholic fatty liver disease was “sufficiently flawed” and 89% preferred nomenclature that described the underlying cause of disease.

Women with metabolic syndrome are more likely to have increased risk for atherosclerotic changes than women without metabolic syndrome, regardless of whether they also have obesity, according to study findings published in Menopause.

A composite biomarker score derived from six metabolites that indicate malnutrition or inflammation provided strong stratification of all-cause mortality in two large, independent cohorts that underwent cardiac catheterization, data show.

WASHINGTON — The term ‘non-alcoholic fatty liver disease’ no longer reflects current knowledge of the disease and should be changed, members of the NAFLD Nomenclature steering committee noted during The Liver Meeting.

Adults who go to sleep later, snore and nap for more than 30 minutes during the day are more likely to develop metabolic dysfunction-associated fatty liver disease, according to study findings.

Phthalates and replacement plasticizers, chemicals used in food packaging and processing, were commonly found in fast-food items, according to a study published in the Journal of Exposure Science & Environmental Epidemiology Qualitative.

Metabolic dysfunction-associated fatty liver disease is highly prevalent among overweight and obese adults, according to Clinical Gastroenterology and Hepatology.

An aerobic exercise program may help improve histologic endpoints in patients with metabolic dysfunction associated fatty liver disease, according to study results.